California Life Sciences Association
250 E. Grand Ave. Suite 26
South San Francisco
95 articles with California Life Sciences Association
CLSA Selects Zuman as Exclusive Provider of HR, Payroll and Benefits Administration Services within CLSA’s Member2Member Program
Zuman to offer price discounts to CLSA Members generally and to those joining the CLSA Benefits Advantage Trust
4/26/2019Companies strengthen leadership teams with C-suite and boards of directors appointments, with new hires at Sandoz, Mission Bio, SkinBio, Epic Sciences, and more.
California Life Sciences Association Expands DC Team, Appoints Director of Federal Government Relations
Molly Fishman Joins CLSA’s Washington, D.C. Office from the Staff of Representative Jackie Speier
The California life Sciences Institutes (CLSI) recently named the winners of the 2019 Amgen Bay Area BioGENEius Challenge. This challenge is a Bay Area competition for high school students that focuses on the students’ individual research projects in the life sciences.Lori Lindburg, president and...
California Life Sciences Association (CLSA) and Congressman Scott Peters Announce Support for New Legislation to Repeal Medical Device Tax
The Protect Medical Innovation Act of 2019, introduced today in the U.S. House, would permanently eliminate the 2.3% excise tax on medical device manufacturers and encourage medical innovation in California
3/22/2019Biotech and pharma companies make appointments to strengthen executive teams, with moves at Sanofi, Forma, Orchard, CLSA, Sangamo, and more.
The life sciences industry is incredibly important to the financial ecosystem of the Golden State. Last year the industry generated total annual revenue of $177.1 billion in the state.
California Life Sciences Association (CLSA) Appoints Andrew Setikas as Senior Vice President of Business Development and Strategy
Life Sciences Industry Leader Andrew Setikas to Take the Helm of CLSA’s Business Development, Membership and Strategic Alliance Activities
3/8/2019Perhaps the biggest mover and shaker announcement this week was the unexpected resignation of Scott Gottlieb, commissioner of the U.S. Food and Drug Administration. Gottlieb will leave his post later this month to spend more time with his family.
New Representation from Edwards Lifesciences and Additions to CLSA Executive Committee Also Announced
California Life Sciences Association Recognizes Senator Jeff Stone and Assemblymembers Chad Mayes, Adam Gray as Champions of Biomedical Innovation
Legislators Honored for Commitment to Strengthening California’s Life Sciences Sector at CLSA’s Back to Session Reception and Dinner in Sacramento
The area is home to numerous well-known players in the pharma industry, including Abbott, Iovance, Gossamer Bio, Crown Biosciences, Illumina, Human Longevity and many, many more.
Despite the significant amount of finances invested in the Bay Area biotech environment, December and January saw a significant number of job cuts.
12/26/2018Companies closed out the year with a number of appointments and hires to strengthen their leadership teams, including changes at the FDA, Melinta, CLSA, Virion, and more.
California Life Sciences Association, the trade association representing California’s life sciences sector, today announced the appointment of Mike Guerra as President and CEO of CLSA effective January 7, 2019.
11/20/2018The number of life science jobs grew by 12,500 for an approximate total of a total estimated employment of 311,226. That was music to the ears of Sara Radcliffe, president and chief executive officer of the California Life Sciences Association.
California saw a 4.2 percent growth of jobs, about 12,500 in total, according to the latest report from the California Life Sciences Association.
Gail Maderis, currently president and chief executive officer of South San Francisco-based Antiva Biosciences, has a rock-solid resume.
California Life Sciences Association (CLSA) Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
H.R. 6378 will bolster U.S. biodefense preparedness and response capabilities
California Life Sciences Association Applauds Governor Brown for Signing SB 1121, Legislation That Protects Clinical Trials and Patient Access in California
SB 1121 Contains Common Sense, Bipartisan Fix to Unintended Consequences of Data Privacy Bill